These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28922525)

  • 1. Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT.
    Tang L; Xu W; Li CG; Hou F; Feng XQ; Wang H; Li XJ; Li WL; Liu JP; Sun LR; Wang SH; Jin J; Fang Q; Luke KH; Poon MC; Blanchette VS; Usuba K; Young NL; Wu R
    Haemophilia; 2018 Jan; 24(1):113-119. PubMed ID: 28922525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia?
    Young NL; Bradley CS; Wakefield CD; Barnard D; Blanchette VS; McCusker PJ
    Pediatr Blood Cancer; 2006 Sep; 47(3):305-11. PubMed ID: 16206209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of health-related quality of life of boys with severe haemophilia A in China: comparing on-demand to prophylaxis treatment.
    Wu R; Sun J; Xiao J; Liu Y; Xue F; Wang H; Tang L; Zhao Y; Li K; Yang R; Hu Y; Luke KH; Poon MC; Blanchette VS; Usuba K; Young NL
    Haemophilia; 2017 May; 23(3):430-436. PubMed ID: 28345299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-cultural adaptation and validation of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) in Côte d'Ivoire (the Ivory Coast).
    Lambert C; Meité ND; Sanogo I; Lobet S; Hermans C; Henrard S; Blanchette V; Young NL
    Health Qual Life Outcomes; 2020 Mar; 18(1):76. PubMed ID: 32188477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Chinese version of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (the CHO-KLAT).
    Wu R; Zhang J; Sun J; Zhou M; Wu JS; Li N; Li X; Luke KH; Poon MC; Blanchette VS; Young NL
    Haemophilia; 2014 Nov; 20(6):794-9. PubMed ID: 25273150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural validation of the CHO-KLAT and HAEMO-QoL-A in Canadian French.
    Young NL; St-Louis J; Burke T; Hershon L; Blanchette V
    Haemophilia; 2012 May; 18(3):353-7. PubMed ID: 22103664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the Portuguese CHO-KLAT in Brazil.
    Villaça PR; Blanchette VS; Carneiro JD; Ozelo MC; Antunes S; Feldman BM; Abad A; Usuba K; Young NL
    Haemophilia; 2016 Nov; 22(6):894-897. PubMed ID: 27456858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in children with haemophilia in China: a 4-year follow-up prospective cohort study.
    Zhang H; Huang J; Kong X; Ma G; Fang Y
    Health Qual Life Outcomes; 2019 Feb; 17(1):28. PubMed ID: 30728017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process and experience of cross-cultural adaptation of a quality of life measure (CHO-KLAT) for boys with haemophilia in Brazil.
    Villaça PR; Carneiro JD; D'Amico EA; Blanchette V; Brandão LR; Cassis FR; Santos VN; Sandoval EP; Burke TA; Young NL
    Haemophilia; 2013 Nov; 19(6):861-5. PubMed ID: 23786255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a health-related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes--Kids Life Assessment Tool (CHO-KLAT).
    Young NL; Bradley CS; Blanchette V; Wakefield CD; Barnard D; Wu JK; McCusker PJ
    Haemophilia; 2004 Mar; 10 Suppl 1():34-43. PubMed ID: 14987247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT tool.
    Carcao M; Zunino L; Young NL; Dover S; Bouskill V; Hilliard P; Price VE; Blanchette VS
    Haemophilia; 2020 Jan; 26(1):73-78. PubMed ID: 31865620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International cross-cultural validation study of the Canadian haemophilia outcomes: kids' life assessment tool.
    McCusker PJ; Fischer K; Holzhauer S; Meunier S; Altisent C; Grainger JD; Blanchette VS; Burke TA; Wakefield C; Young NL
    Haemophilia; 2015 May; 21(3):351-357. PubMed ID: 25471939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China.
    Wu R; Zhang J; Luke KH; Wu X; Burke T; Tang L; Poon MC; Li X; Zhou M; Sun J; Hang M; Blanchette V; Young NL
    Health Qual Life Outcomes; 2012 Sep; 10():112. PubMed ID: 22978454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updating the Canadian hemophilia outcomes-kids life assessment tool (CHO-KLAT Version2.0).
    Young NL; Wakefield C; Burke TA; Ray R; McCusker PJ; Blanchette V
    Value Health; 2013; 16(5):837-41. PubMed ID: 23947978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing two measures of quality of life for children with haemophilia: the CHO-KLAT and the Haemo-QoL.
    Bradley CS; Bullinger M; McCusker PJ; Wakefield CD; Blanchette VS; Young NL
    Haemophilia; 2006 Nov; 12(6):643-53. PubMed ID: 17083516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating the Canadian Hemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) in the era of extended half-life clotting factor concentrates.
    Price VE; Dover S; Blanchette VS; Klaassen RJ; Belletrutti M; Bruce AAK; Chan AK; Wakefield C; Carcao M; Bouskill V; Young NL
    Res Pract Thromb Haemost; 2021 Mar; 5(3):403-411. PubMed ID: 33870026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.
    García-Dasí M; Aznar JA; Jiménez-Yuste V; Altisent C; Bonanad S; Mingot E; Lucía F; Giménez F; López MF; Marco P; Pérez R; Fernández MÁ; Paloma MJ; Galmes B; Herrero S; García-Talavera JA
    Haemophilia; 2015 Jul; 21(4):458-64. PubMed ID: 25649244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long term outcomes analysis of severe haemophilia A boys receiving 4 years prophylaxis on the Chinese Haemophilia Individualized escalating low dose Prophylaxis (CHIPS).
    Yao W; Ai D; Zhang Q; Li X; Zhou M; Zhang N; Yang S; Chen Z; Zhen Y; Luke KH; Wu R
    Thromb Res; 2024 Sep; 241():109110. PubMed ID: 39116483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of life of young patients with haemophilia in Europe].
    Bullinger M; Gringeri A; von Mackensen S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jun; 51(6):637-45. PubMed ID: 18481032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes and practices with regard to circumcision in haemophilia patients in Southern Iran.
    Haghpanah S; Ardeshiri R; Zahedi Z; Golzadeh MH; Silavizadeh S; Karimi M
    Haemophilia; 2013 May; 19(3):e177-8. PubMed ID: 23490218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.